Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.

MLA

Silkoff, Philip E., et al. “Toll-like Receptor 3 Blockade in Rhinovirus-Induced Experimental Asthma Exacerbations: A Randomized Controlled Study.” Journal of Allergy & Clinical Immunology, vol. 141, no. 4, Apr. 2018, pp. 1220–30. EBSCOhost, https://doi.org/10.1016/j.jaci.2017.06.027.

APA

Silkoff, P. E., Flavin, S., Gordon, R., Loza, M. J., Sterk, P. J., Lutter, R., Diamant, Z., Turner, R. B., Lipworth, B. J., Proud, D., Singh, D., Eich, A., Backer, V., Gern, J. E., Herzmann, C., Halperin, S. A., Mensinga, T. T., Del Vecchio, A. M., Branigan, P., & San Mateo, L. (2018). Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study. Journal of Allergy & Clinical Immunology, 141(4), 1220–1230. https://doi.org/10.1016/j.jaci.2017.06.027

Chicago

Silkoff, Philip E., Susan Flavin, Robert Gordon, Mathew J. Loza, Peter J. Sterk, Rene Lutter, Zuzana Diamant, et al. 2018. “Toll-like Receptor 3 Blockade in Rhinovirus-Induced Experimental Asthma Exacerbations: A Randomized Controlled Study.” Journal of Allergy & Clinical Immunology 141 (4): 1220–30. doi:10.1016/j.jaci.2017.06.027.